Rhabdomyolysismuscle breakdown severe enough to cause kidney damageis extraordinarily rare with tirzepatide and has not been documented in clinical trials
By maintaining awareness of potential pancreatic complications, educating patients about warning symptoms, and ensuring appropriate monitoring, healthcare professionals can maximise the benefits of these medications whilst minimising risks
The C-terminal amidation is neither important for the metabolism of GLP-1 nor for its effects on the endocrine pancreas
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
Here is the clinical data and what it means for Canadian users
For those weighing alternatives, the comprehensive weight loss peptide comparison ranks all available options by efficacy and tolerability